Established in 2003 and funded by MEG membership dues, the MEG Award for Student Excellence in Molecular Epidemiology is awarded each year to three early-career scientists whose abstract accepted for presentation at the AACR Annual Meeting has been highly rated by the Program Committee. The purpose of the award is to highlight the work being done by talented early-career scientists and to promote the importance of the field to others who may be considering a career in the growing discipline of molecular epidemiology. Awardees are recognized at the MEG Town Meeting, and automatically become a MEG Working Group member, if they are not already a member.
To be considered for the MEG Award, associate members should indicate that they wish to be considered for a Scholar-in-Training Award when submitting an abstract in the online abstract submitter. All eligible candidates will automatically be considered.
MEG Scholar-in-Training Award Recipients for 2019
Xiang Shu, PhD, MS
Postdoctoral Research Fellow, Division of Epidemiology
Vanderbilt University Medical Center
Identification of circulating protein biomarkers for colorectal cancer risk:
A genetic instrument analysis
Dr. Shu is a molecular epidemiologist by training with a focus on cancer etiology and outcome research. Main areas of his research include identification of novel biomarkers for breast and gastrointestinal cancer via innovative, integrative approaches. He received graduate training from University of Texas Health Science Center and MD Anderson Cancer Center. He is currently a Postdoc Fellow in the Division of Epidemiology at Vanderbilt University Medical Center.
Minisymposium MS.EP01.02. Exposures and Genetics in Cancer Risk Section
Georgia World Congress Center, Room C302
Monday, April 1, 2019, 4:20 - 4:35 p.m.
Audrey Jung, MS, PhD
German Cancer Research Center (DKFZ)
Evaluating multiple tumor markers in a novel analysis of reproductive factors and breast cancer risk
Poster Session PO.EP01.02. Lifestyle Factors and Cancer Risk
Georgia World Congress Center, Exhibit Hall, Section 27
Sunday, March 31, 2019, between 1 – 5 p.m.
Konrad Stopsack, MD, MPH
Research Associate, Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York
Aneuploidy drives lethal progression in prostate cancer
Dr. Stopsack is a molecular cancer epidemiologist whose goal is to help understand etiology and progression of solid tumors such as prostate cancer. He trained in internal medicine at Mayo Clinic and in epidemiology and biostatistics at Harvard T.H. Chan School of Public Health. Funded by the Prostate Cancer Foundation and the Department of Defense, he is currently a research associate in the Department of Medicine at Memorial Sloan Kettering Cancer Center.
Minisymposium MS.EP01.01. Factors Influencing Cancer Outcomes
Georgia World Congress Center, Room A404
Tuesday, April 2, 2019, between 4:20 – 4:35 p.m.